Life update: So excited to share that I’ll be returning to Philly & joining faculty at @PennMedicine as a Classical Hematologist this summer!
@Penn is where I first learned about heme & where I realized I wanted to be a classical hematologist one day! Time to pay it forward!
🎙️#ASCO26: I speak to Dr @GarradEvan for the @JCOOP_ASCO Podcast: What is the current state of AI education w/in oncology training & what is important to consider when developing an AI curriculum?
How should we should evaluate & teach basic AI literacy?
ascopubs.org/do/artificial-i…
Congratulations @GarradEvan!
Another year of oral presentations and simultaneous pub at @ASCO from our work through the HOME consortium! Go team 👏🏻
Our goal is continue to raise bar in #meded research.
Another study being developed soon. If you’re interested, let us know!
Exciting day! Two opportunities to hear the results of our survey on AI use in HO fellowship training.
#1 - Oncology 2.0: How Artificial Intelligence Is Closing the Information GapOr Is It?
📍Room S102
🕑9:45 - 11:15 AM
#AI#ASCO26
A short in-person #ASCO26 for me but leaving feeling energized and inspired about the future of #oncology, #hematology, and #meded!
Looking forward to joining in the fun remotely, especially tomorrow’s session on AI, which includes our project presented by @GarradEvan!
PODCAST-HOF trial featuring @TheFellowOnCall and @TwoOncDocs and published in @JCO_ASCO-OP being highlighted as one of the biggest med ed research studies of the past year to know at the #ASCO26 Medical Education Committee on Practice event! 🎉
So excited to officially kick off the @ASCO LDP: Education Scholars program!
Can’t wait for this year of learning how to be a more effective leader in medical education and as a medical educator
@PennCancer@PennMedicine
W/ #ASCO26 around the corner, tune in for our preview on GU, #MedEd & more:
📖 board review w/ @OncBrothers 5/29!
bit.ly/boards2026
🌟 survey of AI in HOF: 5/31
Not to miss ed sessions:
💊 KRAS- drugs @ASCOPres & @lillian_siu: 5/30 1:15-2:30
🧬 Personalization
🌎 Access
For anyone applying to heme/onc fellowship soon, this podcast episode is for you! 🚨 ‼️
Get inside the head of PDs in this week’s episode developed in collaboration with @ASH_hematology!
With fellowship applications around the corner, many of you are wondering "What are PDs looking for?"
This week, we team up again with Hematopoiesis and @ASH_hematology for "The Ask The Program Directors-The Do’s and Don'ts of Applying to Hematology Fellowship"
Link in bio!
Excited to share that I've been accepted to @ASCO Leadership Development Program: Education Scholars!
Looking forward to working with/learning from colleagues about how to continuously enhance meded, improve mentorship, and strenghthen med ed research!
connection.asco.org/do/asco-…
Let's be real - even after our multi-part series on #multiplemyeloma, treatment is complex and often, our patients don't quite fit the populations in trials. So this week, we start our capstone conversations with #MM experts-asking the hard questions we all want to know
👇
Application closing this week!
MEI is more than training — it’s your laboratory to experiment, innovate, and grow as a hematology educator.
Apply by April 16: ow.ly/qNbT50YEXLz#ASHEducation#ASHTrainee#MedTwitter
Such a hot topic in #Myeloma right now! We also included a fun graphic in our show notes about how to think about sequencing therapies in the relapsed/refractory space. Check it out!
We continue on our R/R myeloma journey, this time shifting our attention to bispecific T-cell engagers, another hot topic right now! 🔥
What are they? How do we use them? Side effects? What's our approach to therapy sequencing?
We cover all this and more!
Link in bio!
Today we're talking about a HOT 🌶️ topic in #myeloma right now - relapsed/refractory disease focusing part 1 of our conversation on CAR T therapy! What are the options? What's the data? Side effects? We go through this and more.
Stay tuned for part 2 next week!
Link in bio
Honored to share that three of my abstracts were accepted to @ASCO 2026, including one selected for oral presentation!
Grateful to my mentors @DrKarineTawagi@FrankWeinbergMD@RyanNguyenDO for their guidance and for bringing me into this work.